Carsten Niemann

Carsten Niemann

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 10 out of 18Page size: 10
Sort by: 1st author
  1. Published

    Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature

    Del Giudice, I., Cappelli, L. V., Delgado, J., Niemann, C. U., Andersen, M. A., Rotbain, E. H. C., Aarup, K., Walewska, R., Visentin, A., Deodato, M., Frustaci, A. M., Cavalloni, C., Gentile, M., Yassin, M. A., Lad, D., Scarfò, L., Flogegard, M., Mattsson, M., Raponi, S., Ilari, C. & 9 others, Starza, I. D., Orlandi, E. M., Tedeschi, A., Trentin, L., Semenzato, G., Guarini, A., Ghia, P., Montserrat, E. & Foà, R., 2023, In: British Journal of Haematology. 201, 2, p. 353-356 4 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  2. Published

    First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

    Eichhorst, B., Niemann, C. U., Kater, A. P., Fürstenau, M., von Tresckow, J., Zhang, C., Robrecht, S., Gregor, M., Juliusson, G., Thornton, P., Staber, P. B., Tadmor, T., Lindström, V., Da Cunha-Bang, C., Schneider, C., Poulsen, C. B., Illmer, T., Schöttker, B., Nösslinger, T., Janssens, A. & 30 others, Christiansen, I., Baumann, M., Frederiksen, H., Van Der Klift, M., Jäger, U., Leys, M. B. L., Hoogendoorn, M., Lotfi, K., Hebart, H., Gaska, T., Koene, H., Enggaard, L., Goede, J., Regelink, J. C., Widmer, A., Simon, F., De Silva, N., Fink, A., Bahlo, J., Fischer, K., Wendtner, C., Kreuzer, K. A., Ritgen, M., Brüggemann, M., Tausch, E., Levin, M., van Oers, M., Geisler, C., Stilgenbauer, S. & Hallek, M., 2023, In: New England Journal of Medicine. 388, 19, p. 1739-1754 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

    Fürstenau, M., Thus, Y. J., Robrecht, S., Mellink, C. H. M., van der Kevie-Kersemaekers, A. M., Dubois, J., von Tresckow, J., Patz, M., Gregor, M., Thornton, P., Staber, P. B., Tadmor, T., Levin, M. D., da Cunha-Bang, C., Schneider, C., Poulsen, C. B., Illmer, T., Schöttker, B., Janssens, A., Christiansen, I. & 27 others, Nösslinger, T., Baumann, M., Hebart, H., Gaska, T., Regelink, J. C., Dompeling, E. C., Lindström, V., Juliusson, G., Widmer, A., Goede, J., Goldschmidt, N., Simon, F., De Silva, N., Fink, A. M., Fischer, K., Wendtner, C. M., Ritgen, M., Brüggemann, M., Tausch, E., Spaargaren, M., Eldering, E., Stilgenbauer, S., Niemann, Carsten, Hallek, M., Eichhorst, B., Kreuzer, K. A. & Kater, A. P., 2023, In: Blood. 142, 5, p. 446–459

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    SOHO State of the Art Updates and Next Questions | Infections in Chronic Lymphocytic Leukemia Patients: Risks and Management

    Gargiulo, E., Ribeiro, E. F. O. & Niemann, Carsten, 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 5, p. 322-332 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives

    Gargiulo, E., Giordano, M., Niemann, Carsten, Moussay, E., Paggetti, J. & Morande, P. E., 2023, In: Frontiers in Oncology. 13, 10 p., 1122699.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut

    Huber, H., Tausch, E., Schneider, C., Edenhofer, S., von Tresckow, J., Robrecht, S., Giza, A., Zhang, C., Fürstenau, M., Dreger, P., Ritgen, M., Illmer, T., Illert, A. L., Dürig, J., Böttcher, S., Niemann, C. U., Kneba, M., Al-Sawaf, O., Kreuzer, K. A., Fink, A. M. & 5 others, Fischer, K., Döhner, H., Hallek, M., Eichhorst, B. & Stilgenbauer, S., 2023, In: Blood. 142, 11, p. 961-972 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation

    Kielbassa, K., Haselager, M. V., Bax, D. J. C., van Driel, B. F., Dubois, J., Levin, M. D., Kersting, S., Svanberg, R., Niemann, Carsten, Kater, A. P. & Eldering, E., 2023, In: Leukemia. 37, 6, p. 1268-1276 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    CD3xCD20 Bispecific Antibodies Yields Long-Term Survival in Relapsed/Refractory B Cell Lymphoma: A Follow-up Study of Patients Treated in Pivotal Phase 1/2 Trials

    Kyvsgaard, Emil Ramsø, Clausen, M. R., Hasselbalch Riley, A. C., Niemann, Carsten, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 28 Nov 2023, In: Blood. 142, Supplement 1, p. 618-618

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Immunohistochemical Tumor Expression Predicts Response to CD3xCD20 Bispecific Antibodies in Patients with Relapsed/Refractory B Cell Lymphoma

    Kyvsgaard, Emil Ramsø, Clausen, M. R., Hasselbalch Riley, A. C., Niemann, Carsten, Sjö, Lene Dissing, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 28 Nov 2023, In: Blood. 142, Supplement 1, p. 6113-6113

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia

    Lorenzovici, L., Szilberhorn, L., Farkas-Ráduly, S., Gasparik, A. I., Precup, A. M., Nagy, A. G., Niemann, Carsten, Aittokallio, T., Kaló, Z. & Csanádi, M., 2023, In: BioDrugs. 37, 2, p. 219-233 15 p.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 Next

ID: 185059285